Clinical management of Class IIi Papanicolaou
Orozco Magaña, I.; Arízaga Cruz, J.M.; Cuevas Torres, A.; Torres Farías, E.
Ginecologia y Obstetricia de Mexico 39(235): 375-381
1976
ISSN/ISBN: 0300-9041 PMID: 803081 Document Number: 101349
Document emailed within 1 workday
Related Documents
Holley, M.R. 1971: Management of the patient with an abnormal Papanicolaou smear American Journal of Obstetrics and Gynecology 110(7): 976-983Chirenje, Z.M. 1994: Management of the patient with an abnormal Papanicolaou smear Central African Journal of Medicine 40(5): 131-134
Spitzer, M.; Krumholz, B.A.; Chernys, A.E.; Seltzer, V.; Lightman, A.R. 1987: Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears Obstetrics and Gynecology 69(5): 731-735
Lojindarat, S.; Luengmettakul, J.; Puangsa-Art, S. 2012: Clinical significance of atypical glandular cells in cervical Papanicolaou smears Journal of the Medical Association of Thailand 95(8): 975-982
Stevermer, J.J.; Wung, L. 2001: Clinical inquiries. Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease? Journal of Family Practice 50(2): 111-112
Güdücü, N.; Gönenç, G.; Işçi, H.; Yiğiter, A.B.şg.ül.; Başsüllü, N.; Dünder, I. 2012: Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears Clinical and Experimental Obstetrics and Gynecology 39(3): 333-336
Leibnitz, R.R.; Lipsky, P.E.; Thiele, D.L. 1995: Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides Journal of Immunology 155(4): 1784-1795
Halimi, A.; Azeroual, M.F.; Abouqal, R.; Zaoui, F. 2011: A comparative study of the transverse dimensions of the dental arches between Class i dental occlusion and Class II1 and Class II2 malocclusions Odonto-Stomatologie Tropicale 34(136): 47-52
Hunter, A.R.; Hunter, A.J. 1989: The Class Ii caries lesion. Part 1: Diagnosis and non-invasive management New Zealand Dental Journal 85(381): 82-86
Abu-Orf, M.M.; Brewster, J.; Oleszkiewicz, J.; Reimers, R.S.; Lagasse, P.; Amy, B.; Glindemann, D. 2004: Production of class A biosolids with anoxic low dose alkaline treatment and odor management Water Science and Technology: a Journal of the International Association on Water Pollution Research 49(10): 131-138
Barber, S.K.; Forde, K.E.; Spencer, R.J. 2015: Class II Division 1: An Evidence- Based Review of Management and Treatment Timing in the Growing Patient Dental Update 42(7): 632
Shen, Z.; Reznikoff, G.; Dranoff, G.; Rock, K.L. 1997: Cloned dendritic cells can present exogenous antigens on both MHC class i and class Ii molecules Journal of Immunology 158(6): 2723-2730
Henderson, S.C.; Berezovskaya, A.; English, A.; Palliser, D.; Rock, K.L.; Bamezai, A. 1998: CD4+ T cells mature in the absence of MHC class i and class Ii expression in Ly-6A.2 transgenic mice Journal of Immunology 161(1): 175-182
Taylor, P.M.; Rose, M.L.; Yacoub, M. 1989: Expression of class i and class Ii MHC antigens in normal and transplanted human lung Transplantation Proceedings 21(1 Part 1): 451-452
Croll, T.P.; Killian, C.M. 1993: Class i and class Ii light-hardened glass-ionomer/resin restorations Compendium 14(7): 908; 910
Mady Maricić, B.; Legović, M.; Slaj, M.; Lapter Varga, M.; Zuvić Butorac, M.; Kapović, M. 2009: Presence of third molar germs in orthodontic patients with class II/2 and class IIi malocclusions Collegium Antropologicum 33(4): 1171-1175
Siala, M.; Mahfoudh, N.; Fourati, H.; Gdoura, R.; Younes, M.; Kammoun, A.; Chour, I.; Meddeb, N.; Gaddour, L.; Hakim, F.; Baklouti, S.; Bargaoui, N.; Sellami, S.; Hammami, A.; Makni, H. 2009: MHC class i and class Ii genes in Tunisian patients with reactive and undifferentiated arthritis Clinical and Experimental Rheumatology 27(2): 208-213
Glimcher, L.H.; McKean, D.J.; Choi, E.; Seidman, J.G. 1985: Complex regulation of class II gene expression: analysis with class II mutant cell lines Journal of Immunology 135(5): 3542-3550
Asnagli, H.; Schmitt-Verhulst, A.M.; Guimezanes, A. 1997: Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions Journal of Immunology 158(10): 4533-4542
Ostrand-Rosenberg, S.; Roby, C.A.; Clements, V.K. 1991: Abrogation of tumorigenicity by MHC class Ii antigen expression requires the cytoplasmic domain of the class Ii molecule Journal of Immunology 147(7): 2419-2422